1. Over-prescription of short-acting β2-agonists is associated with poor asthma outcomes: results from the African cohort of the SABINA III study. (2nd November 2022) Authors: Khattab, Adel; Madkour, Ashraf; Ambaram, Anish; Smith, Clifford; Muhwa, Chakaya J.; Mecha, Jared O.; Alsayed, Mohamed; Beekman, Maarten J. H. I. Journal: Current medical research and opinion Issue: Volume 38:Number 11(2022) Page Start: 1983 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study. Issue 5 (5th May 2022) Authors: Bateman, Eric D.; Price, David B.; Wang, Hao-Chien; Khattab, Adel; Schonffeldt, Patricia; Catanzariti, Angelina; van der Valk, Ralf J.P.; Beekman, Maarten J.H.I. Journal: European respiratory journal Issue: Volume 59:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗